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Membrane phase separationOligomeric species formed during a-synuclein fibrillation are suggested to be membrane-disrupting
agents, and have been associated with cytotoxicity in Parkinson’s disease. The majority of studies,
however, have revealed that the effect of a-synuclein oligomers is only noticeable on systems com-
posed of anionic lipids, while the more physiologically relevant zwitterionic lipids remain intact. We
present experimental evidence for significant morphological changes in zwitterionic membranes
containing cholesterol, induced by a-synuclein oligomers. Depending on the lipid composition,
model membranes are either unperturbed, disrupt, or undergo dramatic morphological changes
and segregate into structurally different components, which we visualize by 2-photon fluorescence
microscopy and generalized polarization analysis using the fluorescent probe Laurdan. Our results
highlight the crucial role of cholesterol for mediating interactions between physiologically relevant
membranes and a-synuclein.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
a-Synuclein (aSN) is an intrinsically disordered protein known
to be implicated in Parkinson’s disease (PD) etiology. A prominent
hallmark of PD is the formation and deposition of cytosolic Lewy
Bodies, with a characteristic rich content of lipids and fibrillated
aSN [1–3]. Such protein fibrils are formed by complex and
supramolecular assembly pathways. Several studies have sug-
gested that intermediate species, rather than the fibril end-
product, are the main toxic species and that interactions between
amyloidogenic proteins and cell membranes are critical to the
onset and progression of PD [4–7]. Accordingly, the unraveling of
the molecular basis of such protein:membrane interactions may
be the key to understand the link between in vivo amyloid forma-
tion and the inherent toxicity [8].The structural and biophysical states of proteins and mem-
branes are likely to be mutually dependent. Membrane physico-
chemical and structural characteristics regulate the protein
aggregation phenomena, and vice versa, which may result in either
promoting or suppressing aggregation and modulating cellular
response to oligomeric proteins [9,10]. Accordingly, studies of tox-
icity mediated by protein:membrane interactions should include
observations of both lipid and protein structural and biophysical
changes [11–13].
By such an approach, we have recently shown that aSN is able
to induce disruption of anionic POPG vesicles, in a process includ-
ing dehydration of the lipid bilayer, resulting in the formation of
dense protein:lipid co-aggregates [13]. Various aSN oligomeric
species have been reported to have membrane-disrupting effects
on pure anionic phosphatidylglycol (PG) liposomes [14–17]. In
contrast, the interaction between aSN and systems composed of
neutral phosphatidylcholine lipids (PC) causes no significant effect
[14–16]. Interestingly, interactions of amyloid-b oligomers and
neutral membranes can be mediated by incorporation of choles-
terol in the membranes [18]. This exemplifies the importance of
varying lipid compositions in model systems, particularly includ-
ing physiological-like compositions, when elucidating protein
and membrane biochemical and biophysical properties [19–21].
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of neutral lipids and cholesterol [22]. Cholesterol plays a crucial
role in regulating membrane structure, plasticity (inducing rigidity
in the bilayer) and functional activity [23] and generally modulates
amyloid protein interactions with lipids [14,18,24]. In the physio-
logical membrane, cholesterol is present at high concentrations
in specific liquid-ordered microdomains, which are thought to
induce specific interaction with proteins and to be implicated in
templating protein aggregation [22]. This highlights the impor-
tance of further investigations of the role of cholesterol-
containing lipid bilayers in context of fibrillating proteins, which
is the focus of the current study.
Different studies of the effect of aSN oligomers on model
systems report seemingly conflicting results. Such recent results
include variations in the reported potency of vesicle disruption
for various types of oligomers [13,15,16]. It is very likely that the
controversy of experimental results arises from finer differences
in the experimental conditions applied in each study. During the
fibrillation reaction, both on- and off-pathway species may be
formed. Particularly stable off-pathway species may be isolated
from the reaction mixtures [16], whereas on-pathway species
are transient intermediates [13,15], only existing in equilibrium
with native and/or fibril species. Such species can hence not be
isolated from the mixtures. As a consequence, studies of the effect
of purified species and mixtures are difficult to compare [17],
although both types of studies are relevant.
This underlines the importance of investigating well-defined
systems. If either the protein or the lipid components of the reac-
tion mixture are poorly defined, observations can be difficult to
interpret. In our previous studies we have used small-angle X-ray
scattering (SAXS) to pre-characterize the protein species, prior to
mixing with the model lipid systems [13]. Interestingly, a strategi-
cally designed small-molecule, the ring-fused 2-pyridone FN075
[25], induces the formation of and stabilizes aSN oligomers whose
core-structure and overall dimensions are analogous to the
on-pathway in-equilibrium oligomers [15,17,26]. The inclusion of
FN075 hence enables the study of the effect of interaction between
the membrane and a well-defined oligomeric state of aSN oligo-
mers (FN-oligomers).
Our present analysis from such well-defined reaction mixtures
reveal, quite unexpectedly, how the presence of cholesterol in neu-
tral membranes drastically changes the effect of FN-oligomers. The
overall effect on cholesterol-containing neutral lipid systems is
distinct from that on anionic lipid systems. In the presence of
cholesterol, FN-oligomers cause the formation of protein:lipid
co-aggregates, as previously reported for anionic membranes [13]
while the remaining membrane moiety exhibits a severely modu-
lated morphology. In a cellular environment, such drastic effects
would significantly alter cell functionality.2. Materials and methods
2.1. FN-oligomer preparation
Recombinant aSN was expressed in E. coli BL21 (DE3) cells
and purified as previously described [13]. FN075 was received
as a kind gift from Almqvist [25]. aSN was dissolved in PBS
buffer (20 mM phosphate, 150 mM NaCl at pH 7.4) and filtered
with 0.22 lm centrifugal filter units (Millipore). FN-oligomers
were prepared from native aSN stock solutions by adding
FN075 in a 6:1 FN075:protein molar ratio followed by whirl
mixing. The concentration of aSN and of FN075 stocks were
determined using extinction coefficients of 5120 M1 cm1 [13]
and 10,000 M1 cm1 [17], respectively.2.2. Preparation of Laurdan stained liposomes
Lipids were purchased from Avanti Polar Lipids. Giant vesicles
(GVs) were prepared from 1-hexadecanoyl-2-(9Z-octadecenoyl)-
sn-glycero-3-phospho-(10rac-glycerol) [POPG], 1-hexadecanoyl-2-
(9Z-octadecenoyl)-sn-glycero-3-phosphocholine [POPC] and POPC:
cholesterol [POPC:chol] in a 1:1 M ratio. The lipid stocks were pre-
pared in chloroform and dried overnight in round flasks on a rotary
evaporator. The dry lipid films were hydrated with 20 mM HEPES
buffer (220 mM KCl, 0.06 mM CaCl2, 0.02 mM EDTA, pH 7.4), mixed
and then sonicated. The resulting lipid solutions were mixed on a
whirl-mixer every 10 min for one hour and left for one more hour
to anneal. GV samples were stained with Laurdan (Sigma Aldrich)
according to standard protocols [27] and left to equilibrate for a
minimum of 3 h before use. Laurdan:lipid molar ratio was 1:400.
2.3. Measurements of membrane biophysics in bulk
Changes of the mobility of water in the membrane were ana-
lyzed by means of Laurdan generalized polarization (GP) described
by Parasassi et al. [28]. Fluorescence measurements of Laurdan
stained GV samples at a lipid concentration of 400 lMwere carried
out on a Jasco FP-8500 equipped with a peltier-thermostat in semi-
micro plastic cuvettes. Emission spectra were measured at 25 C in
the range 370–620 nm under excitation at kexc = 375 nm, (5 nm ex/
em bandwidth, 1 s response time, 100 nm/min scan speed). FN-
oligomers were added to the GVs in lipid:protein (L/P) molar ratios
ranging from 20:1 to 100:1 and the fluorescent emission was
recorded every 4 min after protein addition. The cuvettes were
shaken gently prior to each measurement to keep the samples uni-
formly dispersed. The GP ratio of Laurdan was calculated according
to Parasassi et al. [28]. Control measurements were performed to
ensure that addition of buffers, DMSO or FN075 alone did not alter
the stability of the liposomes. Additional control experiments are
described elsewhere [13].
2.4. Measurements by 2-photon microscopy (2PM)
Laurdan stained GVs were deposited in Chambered Coverglass
(Lab-Tek IINunc). 512  512 pixels image stacks were sequentially
acquired using a Leica TCS SP5 confocal scanning microscope with
a 63 oil objective (Leica Microsystems, Germany). 2-Photon exci-
tation was set at 780 nm (Spectra-Physics Mai-Tai Ti:Sa ultra-fast
laser). Fluorescence signals were simultaneously recorded in two
channels [13,29]: 410–460 nm (blue channel) and 480–540 nm
(green channel). Data were acquired as a function of time before
and after the addition of FN-oligomers. Images were cropped to
256  256 pixels prior to analysis with the SimFCS program (Labo-
ratory for Fluorescence Dynamics, University of California, Irvine,
CA), using either RICS screen or FRET screen of the program. Cali-
bration of the GP scale to obtain a GP = 0.27 for a standard Laurdan
solution in DMSO at 22 C [29]. Control measurements have
revealed that in our experimental conditions and in the absence
of protein the samples, shape and morphology of observed
liposomes do not change within the measurements of time interval
and longer.
3. Results
In Fig. 1 we report spectroscopic measurements of changes in
GP ratios as a function of time after FN-oligomer addition to POPG
(Fig. 1A) and POPC:chol (Fig. 1B) GV bulk samples. GP reports the
changes in Laurdan fluorescence spectra giving valuable informa-
tion on the membrane structural and dynamical properties and
in particular on the level of lipid packing and hydration
Fig. 1. Time evolution of GP ratios obtained from the analysis of Laurdan
fluorescence spectrum variations, measured in bulk. (A) Time evolution of GP
ratios calculated for POPG GV show an increase due to blue shifted fluorescent
emission after addition of aSN FN-oligomers at L/P ratios of 20:1 (circles), 50:1
(squares) and 100:1 (triangles). (B)Time evolution of GP ratios calculated for
POPC:chol GV show a decrease due to overall red shifted fluorescent emission after
addition of aSN FN-oligomers at L/P ratios of 20:1 (circles) and 50:1 (squares).
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ascribed to differences in water penetration into the membrane
between the gel and liquid crystalline phases [30–32]. The results
in Fig. 1A show a concentration dependent increase in GP ratios in
anionic lipid samples. The changes toward higher GP values can be
interpreted as indicative of progressive changes of membrane
fluidity toward an ordered gel phase due to a progressive dehydra-
tion of the lipid bilayer [32]. These results are in line with previous
results on POPG GV analyzed in analogous conditions with
various aSN species, indicating that membrane disruption caused
by reactive aSN species is coupled to an increased rigidity caused
by dehydration of the membrane [13]. In line with previous results
[13], FN-oligomers do not exert any effect on POPC GVs in the same
experimental conditions (see Fig. S1).
Importantly, when aSN FN-oligomers are added to POPC:chol
liposomes 1:1 (Fig. 1B) significant changes are revealed. The
decrease in the GP ratio can be ascribed to changes in the mem-
brane toward an increasingly disordered phase. Note that GP ratio
variations for POPC:chol GV are of a lesser extent and in the oppo-
site direction compared to those for POPG GVs, and also that the
starting GP ratio of POPC:chol is much higher (i.e. a more rigid
structure) than for POPG GVs. Due to their intrinsic ergodic nature
these measurements provide averaged information on the protein:
vesicle interaction and reveal that intrinsically different phenom-
ena occur in the two systems.
Analysis of two-photon microscopy images on analogous sam-
ples allowed us to add topological information. This reveals that
the changes in GP cover are critically different and, particularlyfor the POPC:chol samples, spatially heterogeneous events. Fig. 2
shows 256  256 representative GP maps for POPG and POPC:chol
liposomes as a function of time prior to (panel A and E) and after
the addition of aSN FN-oligomers (panel B–D and panel F–H for
POPG and POPC:chol liposomes respectively). Experiments were
performed by adding FN-oligomers at L/P ratio 50:1 for POPG
and L/P 20:1 for POPC:chol.
GP analysis of 2PM images allows for real time monitoring of
the direct effect of lipid:protein interactions on membrane bio-
physics, integrity and morphology. Data in Fig. 2B–D reveal that
after the addition of aSN FN-oligomers to POPG GVs, the liposomes
are rapidly destroyed leading to a comprehensive depletion of the
liposome population (Movie S1 in SI) combined with an increase of
the number of diffuse pixels characterized by high GP values. The
FN-oligomers, which have been shown to be on-pathway to fibril-
lation [17], thus have the same overall effect on POPG oligomers
(although more potently), as native and partly aggregated aSN
containing a low percentage of transient oligomers [13].
Data in panel F–H show that after the addition of FN-oligomers
(L/P 20:1) POPC:chol GVs undergo critical morphological changes
and structural reorganization as they change in shape, size and
GP distribution (Movies S2 and S3 in SI). Complete depletion of
POPC:chol GVs was never observed, also not at the relatively high
L/P ratios used. It is evident from the high GP, that the overall
structure of the POPC:chol GVs is more rigid than that of POPG
GVs, and that the POPC-cholesterol distribution is natively homo-
geneous within resolution, as expected according to Dietrich
et al. [33]. In line with bulk data (Fig. 1), the average value of GP
for each image progressively decreases with respect to the initial
GP measured before oligomers addition (Fig. 2E), which is clearly
a result of non-homogenous events. The distribution of GP in
POPC:cholGV is progressively heterogeneous leading to spatial
separation of regions with different GP highlighted by blue and
red pixels. Small objects appearing in the surrounding of liposomes
are polydisperse in sizes and they are characterized by higher GP
values compared to the large liposomes present in the sample at
the end of the reaction.
In Fig. 3A and B we report the time evolution of the average
value of GP calculated for each image after the addition of FN-
oligomers. The observed changes are in line with the ones obtained
in bulk experiments, hence revealing that microscopy measure-
ments are representatives of the bulk processes. A deeper analysis
of data in Fig. 2E–H reveal that the lowering of GP for POPC:chol GV
is clearly coupled with the broadening of the distribution of GP
values. Importantly, the reduction of the overall GP simultaneously
with the increase in its distribution width was previously observed
in live cell cultures upon extracellular addition of aggregating
proteins [11].
In Fig. 4A and B we report GP histograms, coming from the same
analysis as in Fig. 2, for POPC:chol GV before and after 29 min of
incubation with aSN FN-oligomers (relative to GP maps in Fig. 2E
and H respectively). In GP histograms it is possible to select pixels
grouped under Gaussian curves, highlighted in red and green, these
pixels will appear with the same color code in the GP maps.
Before protein addition, the GP histogram indicates a fairly
homogeneous distribution of GP within the membrane. The GP his-
togram in panel 4A is well described by a single Gaussian compo-
nent narrowly centered on the average GP = 0.44 as can be seen in
panel (C) where all liposome membranes are colored green. As a
result of protein:membrane interactions, the GP distribution is
broadened so that it can be decomposed into at least two Gaussian
components; one at high GP values (green) and one at low GP val-
ues (red). The green Gaussian component in panel 4B was chosen
with the same width as the one in panel 4A and it is centered at
GP 0.45. The analysis obtained for measurements at other time
intervals after FN-oligomers addition are reported in Fig. S2.
Fig. 2. Representative GP-image maps show distinct biophysical and morphological implications of lipid:protein interactions in POPG and POPC:chol GVs. POPG liposomes
before (A) and 2 (B), 6 (C) and 11 min (D) after the addition of aSN FN-oligomers (L/P 50:1), clearly revealing liposome disintegration. POPC:chol liposomes before (E) and
following 20 (F), 22 (G) and 29 min (H) of addition of aSN FN-oligomers (L/P 20:1) showing re-arrangements of liposome morphology. The color bars indicate the GP of each
pixel ranging from1 (blue) to +1 (red). The width of the images corresponds to 30 lm. Note the formation of an increased background (visible as red dots) over time for both
POPG and POPC:chol samples.
Fig. 3. GP values from 2PM as a function of time showing the GP increase in POPG
(A) and the GP decrease in POPC:chol (B) following the addition of aSN FN-
oligomers. L/P ratio 20:1 (circles) and L/P ratio 50:1 (squares).
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events occur in the sample driving critical modifications in POPC:
chol GV which alter the mobility of water molecules in the
membrane. It is evident that after incubation with FN-oligomers
spatially separated domains with different GP values are formed,
with higher GP values presumably being related to higher choles-
terol content. Thus, it is possible to infer that the presence of
FN-oligomers induces the formation of raft-like microdomains of
discrete local concentrations of POPC and cholesterol.
Fig. 5 shows a representative image of POPC:chol GV after
45 min of incubation with FN-oligomers in the same experiment.
The interaction with oligomers causes changes in the GP spatial
distribution, and in the final state, it is possible to localize sepa-
rated regions characterized by critically different GP values. We
show representative selections of analyzed areas with different
mean GP values including liposome regions with high (green
square) and low GP values (blue square) as well as regions includ-
ing small high GP value, which are appearing during incubation
(red square). The liposomes have a severely altered overall
morphology, but local regions display GP-histograms comparable
to the histograms for non-modified membranes (green box in
Fig. 5), while other regions reveal decreased GP (blue box in
Fig. 5), i.e. increased flexibility in the membrane.
4. Discussion
The observations reported in this letter reveal that the interac-
tions of FN-oligomers with lipid membranes result in different
effects on membrane bilayers, depending on the lipid composition.
We have analyzed model membranes containing cholesterol and
POPC, which are among the major components of synaptic vesicles
[22]. We compare the results to those for anionic phospholipid
membranes. Pure anionic liposomes are often used as in vitro
model systems as they mediate the electrostatic interactions
Fig. 4. GP histograms obtained from the analysis of POPC:chol liposomes sample before (A) and following 29 min (B) of the addition of FN-oligomers: the green and the red
lines are used to select the Gaussian distributions of pixels with different average GP. It is possible to select these pixels in the corresponding binary maps (C, D). Colored
points indicate pixels corresponding to the green and the red selections with the same color code.
Fig. 5. Local variations of GP-distributions in modified liposomes observed with 2PM. The GP-map shows a POPC:chol structure 45 min after aSN-induced modification (L/P
20:1), characterized by regions of distinct local GP-distributions (lower right). Histograms in panel B, C and D are obtained from the analysis of 15 40  40 selections with
analogous properties. The analysis was performed on areas where no intact liposomes are present (e.g. red square, average GP = 0.47) regions on intact liposomes were pixels
with low GP are located (e.g. blue square, average GP = 0.02), regions on intact liposomes were pixels with high GP are located (green square, average GP = 0.39). It is possible
to note that the average GP values of pixels in blue-like selections is close to the GP of single component POPC liposomes.
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are much less abundant than zwitterionic lipids in the membrane
of synaptic vesicles [22].
Designing experimental studies of aSN oligomers is inherently
challenging due to the unstable behavior of aSN oligomers outside
their native environment. The use of chemically stabilized aSN oli-
gomers provides an approach where well-defined on-pathway spe-
cies can be studied undisturbed by the dynamics of ongoing
fibrillation processes [17]. The high disruption potency of aSN
FN-oligomers toward anionic membranes correlates well withprevious findings that identical [17] or related aSN oligomers
[14–16] are able to induce substantial dye release from pure POPG
and DOPG liposomes. The results presented here on the stabilized
aSN oligomers thus highlight the effectiveness of this species in
disturbing anionic membrane integrity. In accordance with previ-
ous reports [13–16] our experiments did not reveal any effects
when FN-oligomers were added to single component POPC GVs.
Moreover, we confirm existing results [18], supporting that
dual-component POPC:chol membranes do interact with amy-
loidogenic oligomers. This is important since it emphasizes that
2666 A. van Maarschalkerweerd et al. / FEBS Letters 589 (2015) 2661–2667the FN-oligomer exhibits a behavior in accordance with other
reports on aSN oligomers, and thus serves as a valid and
well-defined model for the effect of on-pathway aSN fibrillogenic
species [17].
It is not immediately evident how cholesterol facilitates the
interaction between aSN FN-oligomers and vesicles. One effect
may be found in the increased hydrophobicity in the bilayer, and
modified electrostatic interactions in the membrane:solvent
system [35]. Alternatively, the increased lipid head-group spacing
mediated by cholesterol may facilitate protein interactions [14].
Finally, cholesterol is known to affect membrane flexibility by
increasing the packing density of lipids [36–38] which we also
observe by the high starting GP values for the POPC:chol GVs.
Most interestingly, our studies reveal several new lines of evi-
dence. We reveal, firstly, that the net effect of aSN FN-oligomer
addition to POPC:chol vesicles is a decrease in the bulk GP, which
is opposite to that observed for anionic vesicles. Microscopy exper-
iments give further details on the occurring mechanisms, revealing
that two opposite effects occur. Firstly, FN-oligomers modify the
structure of the POPC:chol membrane bilayer, causing the
separation of regions with different GP in the resulting modified
membrane morphology. The GP values and hence the density of
the membrane structures vary greatly in the modified structures,
suggesting that cholesterol no longer is uniformly distributed in
the membrane structures which may potentially lead to a
transition from liquid-order to a mixture of liquid-ordered and
-disordered membrane [39]. Interestingly, the second overall
observation is the simultaneous formation of smaller aggregates
in the background, and these smaller species have increased
GP-values (GP  0.4) (Fig. 2F–H). These objects may be choles-
terol:protein co-aggregates, multicomponent structures including
all three components, or maybe even pure cholesterol clusters
although this last option seems unlikely.
It thus seems that the amyloidogenic protein oligomers while
extracting lipid components and forming protein:lipid co-
aggregates cause a partitioning of the cholesterol containing
zwitterionic vesicles, thereby leaving a modified membrane
structure with islands/rafts of varying ratios of POPC:chol. Such
variations in the lipid composition will lead to local variations in
membrane curvature, and hence result in the modified structures
observed in this study (Fig. 2F–H). It is possible that similar effects
in vivo would lead to significant variations in the membrane mor-
phology or even membrane budding, and hence our observations
could be related to the altered transport and exosomal activities
reported in relation to PD disease progression [40]. The present
data strongly suggest the occurrence of membrane compartmen-
talization and protein lipid co-aggregation this possibly having
important biological implications. These data emphasize the need
for further investigation into protein–lipid interactions and for
characterization of physicochemical properties of co-aggregates.
Others have shown, how changes in the equilibrium of phospho-
lipid:sterol interactions after extraction of cholesterol from lipid
bilayers cause the formation of segregated microdomains with
high POPC content mainly in the disordered liquid phase [35]. Sim-
ilar effects have been reported for amyloid precursor protein in
Alzheimer’s disease cell models, where cholesterol depletion
altered membrane fluidity [41,42].
Our observations thus provide a model for how transiently
formed amyloidogenic oligomers may cause a significant distur-
bance of the affected cells. If we extrapolate our results on the
effect by the Parkinson’s related aSN, this hence suggests that
the neuronal membrane is modulated during disease progression,
by interaction between specific lipid components and aSN oligo-
mers, or a structural species co-existing with these oligomers
[13]. If such aSN amyloidogenic species are able to extract and
co-aggregate with particular lipids, this would result in significantmembrane modulation, including curvature changes and varied
membrane plasticity, thereby potentially causing alterations of
both intra- and extra-cellular signaling, and thus ultimately dis-
turbing the general machinery of the affected neurons.
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